These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35588943)

  • 41. Pharmacogenetics of the human arylamine N-acetyltransferases.
    Grant DM; Goodfellow GH; Sugamori K; Durette K
    Pharmacology; 2000 Sep; 61(3):204-11. PubMed ID: 10971207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of arylamine N-acetyltransferases.
    Butcher NJ; Tiang J; Minchin RF
    Curr Drug Metab; 2008 Jul; 9(6):498-504. PubMed ID: 18680469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues.
    Windmill KF; Gaedigk A; Hall PM; Samaratunga H; Grant DM; McManus ME
    Toxicol Sci; 2000 Mar; 54(1):19-29. PubMed ID: 10746928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
    Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
    Walker K; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):440-72. PubMed ID: 20183529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.
    Stepp MW; Mamaliga G; Doll MA; States JC; Hein DW
    Biochem Biophys Rep; 2015 Sep; 3():45-50. PubMed ID: 26309907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
    Wagner CR; Bergstrom CP; Koning KR; Hanna PE
    Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.
    Dairou J; Dupret JM; Rodrigues-Lima F
    FEBS Lett; 2005 Aug; 579(21):4719-23. PubMed ID: 16098511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
    Hein DW; Zhang X; Doll MA
    Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases.
    Dupret JM; Rodrigues-Lima F
    Curr Med Chem; 2005; 12(3):311-8. PubMed ID: 15723621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes.
    Salazar-González RA; Doll MA; Hein DW
    Sci Rep; 2020 May; 10(1):7566. PubMed ID: 32372066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.
    Wakefield L; Cornish V; Long H; Griffiths WJ; Sim E
    Biochem Biophys Res Commun; 2007 Dec; 364(3):556-60. PubMed ID: 17961509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.
    Sim E; Fakis G; Laurieri N; Boukouvala S
    Adv Pharmacol; 2012; 63():169-205. PubMed ID: 22776642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
    Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
    FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arylamine N-acetyltransferases: from structure to function.
    Sim E; Walters K; Boukouvala S
    Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases.
    Hein DW; Rustan TD; Ferguson RJ; Doll MA; Gray K
    Arch Toxicol; 1994; 68(2):129-33. PubMed ID: 8179482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-acetyltransferase 2 polymorphism in patients with diabetes mellitus.
    Yalin S; Hatungil R; Tamer L; Ates NA; Dogruer N; Yildirim H; Karakas S; Atik U
    Cell Biochem Funct; 2007; 25(4):407-11. PubMed ID: 16397907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
    Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
    PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.